Apple
AAPL
Taylor Morrison Home
TMHC
D.R. Horton
DHI
4
Petroleo Brasileiro SA Petrobras
PBR
5
Vale SA
VALE
US Stock MarketDetailed Quotes
BLUE bluebird bio
- 3.790
- +0.040+1.07%
Close Mar 27 16:00 ET
- 3.635
- -0.155-4.10%
Post 20:01 ET
36.92MMarket Cap-0.11P/E (TTM)
3.810High3.650Low173.30KVolume3.710Open3.750Pre Close647.17KTurnover1.79%Turnover RatioLossP/E (Static)9.74MShares28.60052wk High-6.38P/B36.67MFloat Cap3.56052wk Low--Dividend TTM9.68MShs Float3057.654Historical High--Div YieldTTM4.27%Amplitude3.560Historical Low3.734Avg Price1Lot Size
About bluebird bio Company
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.
Company Profile
SymbolBLUE
Company Namebluebird bio
Listing DateJun 19, 2013
Issue Price17.00
Founded1992
CEOMr. Andrew Obenshain
MarketNASDAQ
Employees375
Fiscal Year Ends12-31
Address455 Grand Union Boulevard
CitySomerville
ProvinceMassachusetts
CountryUnited States of America
Zip Code02145
Phone1-339-499-9300
Websitehttp://www.bluebirdbio.com
Company Executives
- Name
- Position
- Salary
- Andrew Obenshain
- Director, President and Chief Executive Officer
- 3.05M
- O. James Sterling
- Chief Financial Officer and Principal Accounting Officer
- --
- Thomas J. Klima
- Chief Commercial and Operating Officer
- 1.33M
- Richard A. Colvin
- Chief Medical Officer
- 1.34M
- O. James Sterling
- Chief Financial Officer and Principal Accounting Officer
- --
- Joseph Vittiglio
- Chief Legal and Business Officer
- --
- Mark Vachon
- Chairman of the Board
- 200.91K
- Michael Cloonan
- Director
- --
- Nick Leschly
- Director
- 96.41K
- Najoh Tita-Reid
- Independent Director
- 153.91K
- Richard Paulson, M.B.A.
- Independent Director
- 65.24K
- Dr. John O. Agwunobi, M.D.
- Independent Director
- 160.91K
- Dr. Elisabeth Leiderman, M.D.
- Independent Director
- 167.91K
- Dr. Charlotte Jones-Burton, M.D.,M.S.
- Independent Director
- 146.41K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call